Resumen
Objetivo: Analizar el impacto de la obesidad sobre la regulación estrogénica y su relación con el riesgo de cáncer de mama en mujeres premenopáusicas y posmenopáusicas, considerando las diferencias fisiopatológicas, metabólicas y hormonales entre estos períodos. Revisión bibliográfica: La obesidad influye en la regulación estrogénica y en el riesgo de cáncer de mama de manera diferente según el estado menopáusico. En la posmenopausia, el tejido adiposo se convierte en la principal fuente de estrógenos, favoreciendo el hiperestrogenismo periférico y un mayor estímulo proliferativo mamario. En la premenopausia, el exceso de adiposidad puede reducir la función ovárica, asociándose a un menor riesgo global de tumores hormonodependientes; sin embargo, los trastornos metabólicos y la adiposidad central se relacionan con subtipos tumorales más agresivos. Consideraciones finales: La obesidad ejerce un impacto significativo sobre la regulación estrogénica y el riesgo de cáncer de mama, con efectos distintos entre mujeres premenopáusicas y posmenopáusicas. Mientras que en la posmenopausia el hiperestrogenismo periférico asociado a la obesidad contribuye de forma consistente al aumento del riesgo de tumores hormonodependientes, en la premenopausia esta relación es más compleja y está modulada por factores hormonales, metabólicos y por la distribución de la grasa corporal.
Referencias
ALMEIDA LX, et al. Obesidade como fator de risco para o desenvolvimento do câncer de mama em mulheres. Revista de Enfermagem e Atenção à Saúde, 2024; 13: 154–171.
BHARDWAJ P, et al. Estrogens and breast cancer: mechanisms involved in obesity-related development, growth and progression. The Journal of Steroid Biochemistry and Molecular Biology, 2019; 189: 161–170.
CARNEIRO PL, et al. Mortalidade por câncer de mama feminino atribuível ao sobrepeso e obesidade no Brasil. Ciência & Saúde Coletiva, 2025; 30: e12612023.
CHEN H, et al. A relação entre obesidade central e risco de câncer de mama: uma meta-análise de dose-resposta com 7.989.315 mulheres. European Journal of Epidemiology, 2023; 38: 1–15.
DAS GUPTA S, et al. Associations of early-adulthood adiposity with breast parenchymal tissue complexity within premenopausal women. Breast Cancer Research, 2025; 27(1): 188.
DEHESH T, et al. The relation between obesity and breast cancer risk in women by considering menopause status. BMC Women’s Health, 2023; 23: 1–10.
DO NASCIMENTO ANDRÉ AG, et al. Obesidade como fator de risco para câncer de mama: uma revisão integrativa. Revista Foco, 2025; 18(10): e10216.
DUGGAN C, et al. Weight loss reduces circulating micro-RNA related to obesity and breast cancer in postmenopausal women. Epigenetics, 2022; 17(13): 2082–2095.
FREUER D, et al. Body fat distribution and risk of breast, endometrial, and ovarian cancer: a two-sample Mendelian randomization study. Cancers, 2021; 13(20): 5053.
GARCÍA-ESTÉVEZ L, et al. Obesity and breast cancer: a paradoxical and controversial relationship influenced by menopausal status. Frontiers in Oncology, 2021; 11: 705911.
GRAVENA AAF, et al. The obesity and the risk of breast cancer among pre and postmenopausal women. Asian Pacific Journal of Cancer Prevention, 2018; 19: 1–8.
KLINTMAN M, et al. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Research and Treatment, 2022; 196(1): 185–196.
MACCIÒ A, MADEDDU C. Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. The Scientific World Journal, 2011; 11: 2020–2036.
MANE N, et al. Obesity and risk of pre- and postmenopausal breast cancer in Africa: a systematic review. Current Oncology, 2025; 32: 167.
MOTUMA A, et al. Central obesity increases the risk of breast cancer irrespective of menopausal status in women: systematic review and meta-analysis. Cancer Treatment and Research Communications, 2025; 100965.
NEUHOUSER ML, et al. Overweight, obesity and postmenopausal invasive breast cancer risk. JAMA Oncology, 2015; 1(5): 611–621.
ADAMS BD, et al. Exercise and weight loss interventions and miRNA expression in women with breast cancer. Breast Cancer Research and Treatment, 2018; 172(2): 429-438.
PICON M, et al. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. Endocrine-Related Cancer, 2017; 24(6): R215–R229.
SHIRDARREH M, et al. Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review. Breast Cancer, 2021; 28(3): 755–764.
ZUO Q, et al. Breast cancer with positive hormone receptors: epidemiology and mechanisms. Endocrinology, 2021; 162(12): 1–10.
